Liraglutide versus phentermine Liraglutide is the closest GLP-1 to phentermine in terms of efficacy, producing around 8 percent body weight loss at its approved dose
The companies are ordered from largest to smallest in terms of market capitalization
Our role is to distribute the products, we do not offer a nutritional or product advice service
According to the recent findings from Harvard economist Rebecca Diamond in her June 2026 National Bureau of Economic Research working paper, GLP-1Induced Weight Loss and the Female Obesity Penalty, women who were not employed when they began taking GLP-1 medications for weight loss experienced a significant change in their employment prospects after 18 months of usage
The records, spanning the period from 2022 through mid-2025, showed that more than 15,000 of the women had a prescription for GLP-1 medications, and more than 96,000 had no records of GLP-1 prescriptions